Literature DB >> 22420613

Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.

K Huang1, C Huang, K Shan, J Chen, H Li.   

Abstract

BACKGROUND: PC cell-derived growth factor (PCDGF) is an autocrine growth factor originally purified from the highly tumorigenic teratoma PC cell line. It participates in tumorigenesis and tumour progression through upregulation of cyclin D1. To date, there has been no report on the role of PCDGF in skin cancer, to our knowledge. AIM: To investigate the expression of PCDGF and cyclin D1 in basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and seborrhoeic keratosis (SK), and their relationship with the clinicopathological parameters of SCC.
METHODS: Immunohistochemical expression of PCDGF and cyclin D1 was examined in 42 SCC, 30 BCC and 20 SK tissues.
RESULTS: PCDGF and cyclin D1 were overexpressed in SCC or BCC tissues compared with normal skin or SK, and their expressions were significantly higher in SCC than in BCC. Moreover, positive expression of PCDGF and cyclin D1 was significantly correlated with depth of invasion and metastasis of SCC. There was significant correlation between PCDGF and cyclin D1 expression in SCC.
CONCLUSIONS: Expression of PCDGF and cyclin D1 plays an important role in the tumorigenesis of BCC and SCC. Abnormal expression of PCDGF and Cyclin D1 may be related to invasion and metastasis of SCC. © The Author(s). CED
© 2012 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22420613     DOI: 10.1111/j.1365-2230.2011.04275.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  9 in total

1.  Progranulin is preferentially expressed in patients with psoriasis vulgaris and protects mice from psoriasis-like skin inflammation.

Authors:  Kun Huang; Aijun Chen; Xuemei Zhang; Zhixin Song; Hongmei Xu; Ju Cao; Yibing Yin
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

Review 2.  Progranulin and its biological effects in cancer.

Authors:  Fabian Arechavaleta-Velasco; Carlos Eduardo Perez-Juarez; George L Gerton; Laura Diaz-Cueto
Journal:  Med Oncol       Date:  2017-11-07       Impact factor: 3.064

3.  Cyclin D1 localizes in the cytoplasm of keratinocytes during skin differentiation and regulates cell-matrix adhesion.

Authors:  Rita Fernández-Hernández; Marta Rafel; Noel P Fusté; Rafael S Aguayo; Josep M Casanova; Joaquim Egea; Francisco Ferrezuelo; Eloi Garí
Journal:  Cell Cycle       Date:  2013-07-08       Impact factor: 4.534

4.  Cyclin D1 expression in Bowen's disease and cutaneous squamous cell carcinoma.

Authors:  Yanyun Shen; Jinhua Xu; Jin Jin; Hui Tang; Jun Liang
Journal:  Mol Clin Oncol       Date:  2014-04-01

5.  Progranulin Inhibits Human T Lymphocyte Proliferation by Inducing the Formation of Regulatory T Lymphocytes.

Authors:  Kyu Hwan Kwack; Hyeon-Woo Lee
Journal:  Mediators Inflamm       Date:  2017-01-17       Impact factor: 4.711

Review 6.  Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.

Authors:  Luca Fania; Dario Didona; Francesca Romana Di Pietro; Sofia Verkhovskaia; Roberto Morese; Giovanni Paolino; Michele Donati; Francesca Ricci; Valeria Coco; Francesco Ricci; Eleonora Candi; Damiano Abeni; Elena Dellambra
Journal:  Biomedicines       Date:  2021-02-09

Review 7.  Oh, the Mutations You'll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma.

Authors:  Stephenie Droll; Xiaomin Bao
Journal:  Cell Physiol Biochem       Date:  2021-09-22

8.  Targeting PRPK and TOPK for skin cancer prevention and therapy.

Authors:  Eunmiri Roh; Mee-Hyun Lee; Tatyana A Zykova; Feng Zhu; Janos Nadas; Hong-Gyum Kim; Ki Beom Bae; Yan Li; Yong Yeon Cho; Clara Curiel-Lewandrowski; Janine Einspahr; Sally E Dickinson; Ann M Bode; Zigang Dong
Journal:  Oncogene       Date:  2018-06-14       Impact factor: 9.867

Review 9.  A narrative review of multiple mechanisms of progranulin in cancer: a potential target for anti-cancer therapy.

Authors:  Chenhui Zhou; Yi Huang; Jingmi Wu; Yiting Wei; Xiaosheng Chen; Zhiqing Lin; Sheng Nie
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.